TradingView
RocketTickers
Apr 9, 2019 9:31 PM
FDA Approves EVENITY(TM) (romosozumab-aqqg) For The Treatment
Long
NASDAQ:AMGN
1D
Amgen Inc.
NASDAQ
Description
⋅
Apr 9, 2019 9:31 PM
AMGN: Amgen
2019-04-09 15:57:00
FDA Approves EVENITY(TM) (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture - PR Newswire
Beyond Technical Analysis
More